About Combinostics
Combinostics is a company based in Finland founded in 2014 by Jussi Mattila, Jyrki Lotjonen, and Lennart Thurfjell was acquired by SyntheticMR in November 2024. Combinostics has raised $4.3 million across 5 funding rounds from investors including European Union, SyntheticMR and Industrifonden. The company has 3 employees as of December 31, 2022. Combinostics offers products and services including cNeuro Platform, cMRI, cDSI, and cPET and cDAT. Combinostics operates in a competitive market with competitors including Medical Brain, Neurobrave, Nile, iMed Technologies and RedOak Instruments, among others.
- Headquarter Finland
- Employees 3 as on 31 Dec, 2022
- Founders Jussi Mattila, Jyrki Lotjonen, Lennart Thurfjell
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Combinostics Us Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.3 M (USD)
in 5 rounds
-
Latest Funding Round
$475.32 K (USD), Grant
Jan 01, 2021
-
Investors
European Union
& 4 more
-
Employee Count
3
as on Dec 31, 2022
-
Acquired by
SyntheticMR
(Nov 28, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Combinostics
Combinostics offers a comprehensive portfolio of products and services, including cNeuro Platform, cMRI, cDSI, and cPET and cDAT.
Comprehensive platform for managing neurological disorders via data integration.
Fully automated tool for brain MRI analysis and abnormality detection.
AI system for differential diagnosis using patient data and imaging.
Tools for quantifying SPECT images and supporting nuclear medicine diagnostics.
People of Combinostics
Unlock access to complete
Funding Insights of Combinostics
Combinostics has successfully raised a total of $4.3M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $475.32 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Combinostics
Combinostics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, SyntheticMR and Industrifonden.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in deep-tech, life sciences, and transformative tech are managed.
|
Locked | Locked | Locked | |
|
A venture capital firm investing in sustainable and deep-tech startups
|
Locked | Locked | Locked | |
|
CakhiaTV is operated as a football streaming and news platform.
|
Locked | Locked | Locked |
Investor details for Combinostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Combinostics
Investment portfolio details for Combinostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Combinostics
Detailed financials for Combinostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Combinostics Comparisons
Peer comparison for Combinostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Combinostics
Combinostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medical Brain, Neurobrave, Nile, iMed Technologies and RedOak Instruments, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Actionable insights for neurological conditions are generated via AI platform.
|
|
| Locked | Locked | Locked |
Cloud-based neurology disease detection tool for healthcare professionals
|
|
| Locked | Locked | Locked |
AI-based epilepsy management tools are provided to patients and providers.
|
|
| Locked | Locked | Locked |
Developer of AI-based video analysis technology for surgery support
|
|
| Locked | Locked | Locked |
Developer of device for injury and motor skills monitoring
|
Detailed competitors of Combinostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Combinostics
Complete news archive for Combinostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Combinostics
Combinostics was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Combinostics is headquartered in Finland.
Lennart Thurfjell is the current CEO of Combinostics. They have also founded this company.
Combinostics is a funded company, having raised a total of $4.3M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Combinostics is 3.
Combinostics was founded in 2014 in Finland, with operations centered on AI applications in the healthcare sector. Neurological disorders such as dementia, multiple sclerosis, traumatic brain injury, and epilepsy are addressed through the cloud-based cNeuro platform. Products including cNeuro cMRI and cNeuro cDSI are integrated with external data sources to support comprehensive patient management, diagnosis, and detection processes.
Combinostics's top competitors include Medical Brain, Nile and Neurobrave.
Combinostics offers cNeuro Platform, cMRI, cDSI, and cPET and cDAT.
Combinostics has 5 investors. Key investors include European Union, SyntheticMR, Industrifonden, NordicNinja, and CakhiaTV.